{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:45:40Z","timestamp":1778251540030,"version":"3.51.4"},"publisher-location":"Chichester, UK","reference-count":156,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004371.pub3","type":"reference-entry","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T11:30:21Z","timestamp":1268739021000},"source":"Crossref","is-referenced-by-count":69,"title":["Interventions to improve adherence to lipid lowering medication"],"prefix":"10.1002","author":[{"given":"Angela","family":"Schedlbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0002-9149(97)00303-2","article-title":"Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg\/dl in patients with hyperlipidemia and coronary artery disease","volume":"80","author":"Brown","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1592\/phco.20.5.410.35048","article-title":"Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial","volume":"20","author":"Faulkner","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0149-2918(01)80084-9","article-title":"The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program","volume":"23","author":"Guthrie","year":"2001","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB4|cit4","first-page":"79","article-title":"Therapeutic compliance in dyslipidemias. A trial of the efficacy of health education","volume":"22","author":"Marquez Contreras","year":"1998","journal-title":"Atencion Primaria"},{"issue":"8","key":"10.1002\/14651858.CD004371.pub3-BIB5|cit5","first-page":"15","article-title":"Efficacy of an intervention to improve therapy compliance in lipaemia cases","volume":"33","author":"Marquez Contreras","year":"2004","journal-title":"Atencion Primaria"},{"issue":"12","key":"10.1002\/14651858.CD004371.pub3-BIB6|cit6","first-page":"661","article-title":"Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective?","volume":"39","author":"Marquez Contreras","year":"2007","journal-title":"Atencion Primaria"},{"issue":"10","key":"10.1002\/14651858.CD004371.pub3-BIB7|cit7","first-page":"31","article-title":"The medication use study","volume":"131","author":"Poston","year":"1998","journal-title":"Canadian Pharmaceutical Journal"},{"issue":"20","key":"10.1002\/14651858.CD004371.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/ajhp\/52.20.2196","article-title":"Failure of educational videotapes to improve medication compliance in a health maintenance organization","volume":"52","author":"Powell","year":"1995","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/106002809402800104","article-title":"Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy","volume":"28","author":"Schectman","year":"1994","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0002-9343(91)80087-3","article-title":"Efficacy and compliance with cholestyramine bar versus powder in the treatment of hyperlipidemia","volume":"90","author":"Sweeney","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1198","article-title":"Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin","volume":"15","author":"Vrijens","year":"2006","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00005082-200001000-00007","article-title":"Cholesterol management: an opportunity for nurse case managers","volume":"14","author":"Allen","year":"2000","journal-title":"Journal of Cardiovascular Nursing"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0002-8703(02)00141-2","article-title":"Nurse case management of hypercholesterolemia in patients with coronary heart disease: Results of a randomized clinical trial","volume":"144","author":"Allen","year":"2002","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD004371.pub3-BIB14|cit14","first-page":"467","article-title":"Effective strategies to improve adherence to drug prescription","volume":"11","author":"Alvarez","year":"2001","journal-title":"Medifam - Revista de Medicina Familiar y Comunitaria"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB15|cit15","first-page":"378","article-title":"Pharmacist-managed lipid program reduces medication costs despite increase in drug utilization","volume":"36","author":"Anonymous","year":"2001","journal-title":"Hospital Formulary"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB16|cit16","first-page":"356","article-title":"Risk factors for CHD not being identified","volume":"8","author":"Anonymous","year":"2001","journal-title":"British Journal of Cardiology"},{"issue":"7224","key":"10.1002\/14651858.CD004371.pub3-BIB17|cit17","first-page":"706","article-title":"Is alternate day dosing more cost-effective?","volume":"269","author":"Anonymous","year":"2002","journal-title":"Pharmaceutical Journal"},{"issue":"7170","key":"10.1002\/14651858.CD004371.pub3-BIB18|cit18","first-page":"558","article-title":"Supporting the implementation of prescribing advice in PCOs","volume":"267","author":"Ashcroft","year":"2001","journal-title":"Pharmaceutical Journal"},{"issue":"8","key":"10.1002\/14651858.CD004371.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1185\/030079902125001317","article-title":"Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"18","author":"Athyros","year":"2002","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB20|cit20","first-page":"169","article-title":"Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: Evaluation of a nurse-oriented management approach","volume":"17","author":"Baillargeon","year":"2001","journal-title":"Canadian Journal of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD004371.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archinte.158.14.1533","article-title":"Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease","volume":"158","author":"Becker","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1745-7599.2001.tb00021.x","article-title":"Improving compliance in your dyslipidemic patient: an evidence-based approach","volume":"13","author":"Becker","year":"2001","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB23|cit23","first-page":"158","article-title":"The physician and pharmacist team. An effective approach to cholesterol reduction","volume":"12","author":"Bogden","year":"1997","journal-title":"Journal of General Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004371.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1592\/phco.20.17.1375.34895","article-title":"Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals","volume":"20","author":"Bozovich","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0895-4356(99)00019-0","article-title":"Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia: CREOLE Study Team","volume":"52","author":"Bruckert","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00008483-199004000-00006","article-title":"Frequent cholesterol feedback as an aid in lowering cholesterol levels","volume":"10","author":"Burkett","year":"1990","journal-title":"Journal of Cardiopulmonary Rehabilitation"},{"issue":"12","key":"10.1002\/14651858.CD004371.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/00001888-199912000-00018","article-title":"An intervention to increase physicians' use of adherence-enhancing strategies in managing hypercholesterolemic patients","volume":"74","author":"Casebeer","year":"1999","journal-title":"Academic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/ajhp\/62.4.411","article-title":"Assessing adherence to statin therapy using patient report, pill count, and an electronic monitoring device","volume":"62","author":"Cheng","year":"2005","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0005-7894(82)80061-0","article-title":"Frequency of contact and monetary reward in weight loss, lipid change, and blood pressure reduction with adolescents","volume":"13","author":"Coates","year":"1982","journal-title":"Behavior Therapy"},{"issue":"9 I","key":"10.1002\/14651858.CD004371.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1592\/phco.22.13.1110.33518","article-title":"Daily dosing versus alternate-day dosing of simvastatin in patients with hypercholesterolemia","volume":"22","author":"Copher","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD004371.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-120-9-199405010-00001","article-title":"A case-management system for coronary risk factor modification after acute myocardial infarction","volume":"120","author":"DeBusk","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004371.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/diacare.23.11.1619","article-title":"The Diabetes Prevention Program: baseline characteristics of the randomized cohort","volume":"23","year":"2000","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD004371.pub3-BIB33|cit33","first-page":"973","article-title":"A pharmacy-based approach to cholesterol management","volume":"7","author":"Ditusa","year":"2001","journal-title":"American Journal of Managed Care"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0895-4356(94)00221-B","article-title":"Effects of \"group detailing\" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care","volume":"48","author":"Diwan","year":"1995","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0738-3991(94)90009-4","article-title":"A comparison of education methods and their impact on behavioral change in patients with hyperlipidemia","volume":"24","author":"Dobs","year":"1994","journal-title":"Patient Education and Counseling"},{"issue":"24","key":"10.1002\/14651858.CD004371.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/ajhp\/57.24.2285","article-title":"Low-density-lipoprotein cholesterol in patients treated by a lipid clinic versus a primary care clinic","volume":"57","author":"Dunham","year":"2000","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/ewjm.173.3.185","article-title":"In people with no evidence of cardiovascular disease, how effective are interventions aimed at controlling risk factors in reducing all-cause and coronary artery disease mortality?","volume":"173","author":"Ebrahim","year":"2000","journal-title":"Western Journal of Medicine"},{"issue":"1065","key":"10.1002\/14651858.CD004371.pub3-BIB38|cit38","first-page":"170","article-title":"Evidence based strategies for secondary prevention of ischaemic heart disease: Time to improve clinical practice","volume":"1111","author":"Ellis","year":"1998","journal-title":"New Zealand Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD004371.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1592\/phco.20.19.1508.34852","article-title":"Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers","volume":"20","author":"Ellis","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2796.1998.00294.x","article-title":"Compliance with and efficacy of treatment with pravastatin and cholestyramine: A randomized study on lipid-lowering in primary care","volume":"243","author":"Eriksson","year":"1998","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD004371.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0021-9150(97)88360-8","article-title":"Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care","volume":"134","author":"Eriksson","year":"1997","journal-title":"Athereosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/ewjm.175.3.165","article-title":"Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial","volume":"175","author":"Frances","year":"2001","journal-title":"Western Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB43|cit43","first-page":"e134","article-title":"Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention","volume":"3","author":"Fretheim","year":"2006","journal-title":"PLoS Medicine \/ Public Library of Science"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1022695119046","article-title":"Automated telephone conversations to assess health behavior and deliver behavioral interventions","volume":"22","author":"Friedman","year":"1998","journal-title":"Journal of Medical Systems"},{"issue":"9153","key":"10.1002\/14651858.CD004371.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10557-005-5057-9","article-title":"The statin breakthrough - Remembering to involve the patient","volume":"18","author":"Gaw","year":"2004","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"6 I","key":"10.1002\/14651858.CD004371.pub3-BIB48|cit48","first-page":"298","article-title":"Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program","volume":"13","author":"Hae","year":"2007","journal-title":"American Journal of Managed Care"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2796.1997.112133000.x","article-title":"The problem of compliance to cholesterol altering therapy","volume":"241","author":"Insull","year":"1997","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0749-3797(18)30703-7","article-title":"Use and outcomes of a cholesterol-lowering intervention for rural elderly subjects","volume":"9","author":"Ives","year":"1993","journal-title":"American Journal of Preventive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004371.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/107424840300800205","article-title":"Efficacy of alternate-day dosing versus daily dosing of atorvastatin","volume":"8","author":"Jafari","year":"2003","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD004371.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1365-2702.2007.01838.x","article-title":"A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China","volume":"16","author":"Jiang","year":"2007","journal-title":"Journal of Clinical Nursing"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2796.1996.491830000.x","article-title":"The cost effectiveness of lipid lowering in Swedish primary health care. The CELL Study Group","volume":"240","author":"Johannesson","year":"1996","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/dis.2006.9.102","article-title":"Transtheoretical model intervention for adherence to lipid-lowering drugs","volume":"9","author":"Johnson","year":"2006","journal-title":"Disease Management"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/fampra\/15.6.548","article-title":"Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project","volume":"15","author":"Jolly","year":"1998","journal-title":"Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archfami.6.2.135","article-title":"A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project","volume":"6","author":"Keyserling","year":"1997","journal-title":"Archives of Family Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004371.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pds.730","article-title":"Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients","volume":"11","author":"Kim","year":"2002","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0002-9149(01)01612-5","article-title":"Effectiveness of the electronic medical record in cholesterol management in patients with coronary artery disease (Virtual Lipid Clinic)","volume":"88","author":"Kinn","year":"2001","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2710.2000.00315.x","article-title":"Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients","volume":"25","author":"Kiortsis","year":"2000","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD004371.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2337\/diacare.17.8.840","article-title":"A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors","volume":"17","author":"Kirkman","year":"1994","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.CIR.82.5.1616","article-title":"Mortality after 10 1\/2 years for hypertensive participants in the multiple risk factor intervention trial","volume":"82","author":"Kjelsberg","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/j.1875-9114.1997.tb03068.x","article-title":"Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans","volume":"17","author":"Konzem","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB64|cit64","first-page":"6","article-title":"Protocol helps drug adherence","volume":"19","author":"Kuznar","year":"2002","journal-title":"Cardiology Review"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-000-0086-0","article-title":"Poor compliance: the hidden risk factor","volume":"2","author":"LaRosa","year":"2000","journal-title":"Current Atherosclerosis Reports"},{"issue":"10","key":"10.1002\/14651858.CD004371.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archfami.9.10.1169","article-title":"Enhancing drug compliance in lipid-lowering treatment","volume":"9","author":"LaRosa","year":"2000","journal-title":"Archives of Family Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/0091270004265364","article-title":"Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong","volume":"44","author":"Lee","year":"2004","journal-title":"Journal of Clinical Pharmacology"},{"issue":"21","key":"10.1002\/14651858.CD004371.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.296.21.joc60162","article-title":"Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial","volume":"296","author":"Lee","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB69|cit69","first-page":"2007","article-title":"How should we measure medication adherence in clinical trials and practice?","volume":"3","author":"Lee","year":"2007","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0197-2456(00)00088-X","article-title":"Estimating the power of compliance - Improving methods","volume":"21","author":"Lesaffre","year":"2000","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1370\/afm.423","article-title":"Effects of enhanced depression treatment on diabetes self-care","volume":"4","author":"Lin","year":"2006","journal-title":"Annals of Family Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2796.1996.492831000.x","article-title":"Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study","volume":"240","author":"Lindholm","year":"1996","journal-title":"Journal of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00124784-199711000-00015","article-title":"A lipid trial tracking system","volume":"3","author":"Merriam","year":"1997","journal-title":"Journal of Public Health Management and Practice"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/ebn.5.2.54","article-title":"Review: multidisciplinary disease management programmes do not reduce death or recurrent myocardial infarction but reduce admission to hospital","volume":"5","author":"Micevski","year":"2002","journal-title":"Evidence-Based Nursing"},{"issue":"7298","key":"10.1002\/14651858.CD004371.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/bmj.322.7298.1338","article-title":"Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care","volume":"322","author":"Moher","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0149-2918(02)85016-0","article-title":"Effect of early telephone and postal reminders on medication compliance with pravastatin therapy","volume":"24","author":"Noel","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ajhp\/58.4.325","article-title":"Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic","volume":"58","author":"O'Donnell","year":"2001","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"11","key":"10.1002\/14651858.CD004371.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ajhp\/58.11.1017","article-title":"Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic","volume":"58","author":"O'Donnell","year":"2001","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0011-393X(98)85009-1","article-title":"Escape phenomenon with pravastatin during long-term treatment of patients with hyperlipidemia associated with diabetes mellitus","volume":"59","author":"Oi","year":"1998","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"9","key":"10.1002\/14651858.CD004371.pub3-BIB80|cit80","first-page":"465","article-title":"The validity of 6 indirect methods for assessing compliance with pharmacological treatment in dyslipidemias","volume":"19","author":"Pineiro","year":"1997","journal-title":"Atencion Primaria"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1464-5491.2002.00701.x","article-title":"Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus: a randomized prospective study","volume":"19","author":"Rachmani","year":"2002","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB82|cit82","first-page":"36","article-title":"Nurses counseling for hypercholesterolemia: Efficient strategy in middle-aged men","volume":"6","author":"Rastam","year":"1996","journal-title":"Cardiovascular Risk Factors"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/j.1875-9114.1998.tb03905.x","article-title":"A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia","volume":"18","author":"Rindone","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD004371.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","article-title":"Patient adherence and medical treatment outcomes: a meta-analysis","volume":"40","author":"Robin","year":"2002","journal-title":"Medical Care"},{"issue":"13","key":"10.1002\/14651858.CD004371.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"866","DOI":"10.12968\/bjon.2000.9.13.5515","article-title":"Pharmacological interventions in type 2 diabetes: the role of nurses","volume":"9","author":"Rodgers","year":"2000","journal-title":"British Journal of Nursing"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.amjcard.2004.04.024","article-title":"Safety and compliance with once-daily niacin extended-release\/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study","volume":"94","author":"Rubenfire","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02598268","article-title":"Physician extenders for cost-effective management of hypercholesterolemia","volume":"11","author":"Schectman","year":"1996","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB88|cit88","first-page":"216","article-title":"Life style changes in patients with myocardial infarct in the framework of intramural and ambulatory rehabilitation--results of a German pilot study","volume":"84","author":"Scherwitz","year":"1995","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/00912709922007976","article-title":"Electronic monitoring of compliance to lipid-lowering therapy in clinical practice","volume":"39","author":"Schwed","year":"1999","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1067\/mhj.2001.118739","article-title":"Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease","volume":"142","author":"Senaratne","year":"2001","journal-title":"American Heart Journal"},{"issue":"21","key":"10.1002\/14651858.CD004371.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1001\/archinte.1995.00430210080012","article-title":"Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care","volume":"155","author":"Shaffer","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005082-199101000-00008","article-title":"Research connections: treating hypercholesterolemia","volume":"5","author":"Shively","year":"1991","journal-title":"Journal of Cardiovascular Nursing"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1592\/phco.21.6.627.34538","article-title":"Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists","volume":"21","author":"Simpson","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD004371.pub3-BIB94|cit94","doi-asserted-by":"crossref","unstructured":"Toobert DJ Glasgow RE Radcliffe JL Physiologic and related behavioral outcomes from the women's lifestyle heart trial Annals of Behavioural Medicine 2000 1 16","DOI":"10.1007\/BF02895162"},{"issue":"9","key":"10.1002\/14651858.CD004371.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1345\/aph.18380","article-title":"Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk","volume":"33","author":"Tsuyuki","year":"1999","journal-title":"Annals of Pharmacotherapy"},{"issue":"10","key":"10.1002\/14651858.CD004371.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archinte.162.10.1149","article-title":"A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)","volume":"162","author":"Tsuyuki","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004371.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1345\/aph.19374","article-title":"Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice","volume":"34","author":"Tully","year":"2000","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00019053-199915030-00002","article-title":"Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens","volume":"15","author":"Urquhart","year":"1999","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB99|cit99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0895-4356(01)00460-7","article-title":"Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the \"real world\"--randomized controlled trial","volume":"55","author":"Vale","year":"2002","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/14635240.1999.10806088","article-title":"A health promotion programme for the prevention of cardiovascular diseases in the elderly","volume":"37","author":"Velonakis","year":"1999","journal-title":"International Journal of Health Promotion and Education"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00008483-199811000-00002","article-title":"Comprehensive cardiac rehabilitation improves the control of dyslipidemia in secondary prevention","volume":"18","author":"Verges","year":"1998","journal-title":"Journal of Cardiopulmonary Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pds.2630040203","article-title":"Hyperlipidaemia in primary care - A randomized controlled trial on treatment information in Sweden: Design and methodology","volume":"4","author":"Wahlstrom","year":"1995","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/heart.88.3.229","article-title":"Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study","volume":"88","author":"Wei","year":"2002","journal-title":"Heart (British Cardiac Society)"},{"issue":"10","key":"10.1002\/14651858.CD004371.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archinte.167.10.1076","article-title":"Helping patients with type 2 diabetes mellitus make treatment decisions: Statin choice randomized trial","volume":"167","author":"Weymiller","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004371.pub3-BIB105|cit105","first-page":"S15","article-title":"The specialist nurse in coronary heart disease prevention: Evidence for effectiveness","volume":"9 Suppl 3","author":"Wright","year":"2002","journal-title":"British Journal of Cardiology"},{"issue":"7567","key":"10.1002\/14651858.CD004371.pub3-BIB106|cit106","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/bmj.38905.447118.2F","article-title":"Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: Randomised controlled trial","volume":"333","author":"Wu","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1536\/jhj.45.959","article-title":"Comparison of intermittent with continuous simvastatin treatment in hypercholesterolemic patients with end stage renal failure","volume":"45","author":"Yigit","year":"2004","journal-title":"Japanese Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB108|cit108","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10557-005-5202-5","article-title":"Being well-informed about statin is associated with continuous adherence and reaching targets","volume":"19","author":"Yilmaz","year":"2005","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"20","key":"10.1002\/14651858.CD004371.pub3-BIB109|cit109","first-page":"76","article-title":"Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: A randomised controlled trial","volume":"6","author":"Zermansky","year":"2002","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"8934","key":"10.1002\/14651858.CD004371.pub3-BIB110|cit110","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"issue":"9209","key":"10.1002\/14651858.CD004371.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","article-title":"Subgroup analysis and other (mis)uses of baseline data in clinical trials","volume":"355","author":"Assmann","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"18","author":"Athyros","year":"2002","journal-title":"Current Medical Research and Opinion"},{"issue":"18","key":"10.1002\/14651858.CD004371.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.279.18.1458","article-title":"Persistence of Use of Lipid-Lowering Medications","volume":"279","author":"Avorn","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB114|cit114","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD004371.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1592\/phco.2005.25.8.1035","article-title":"Cardiovascular morbidity associated with nonadherence to statin therapy","volume":"25","author":"Blackburn","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB116|cit116","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2125.2004.02202.x","article-title":"Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease","volume":"58","author":"Cheng","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD004371.pub3-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004371.pub3-BIB118|cit118","article-title":"Assessment of study quality (updated April 2002); Section 6","volume-title":"The Cochrane Reviewers Handbook","author":"Clarke","year":"2002"},{"key":"10.1002\/14651858.CD004371.pub3-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD004371.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0091-7435(85)90070-2","article-title":"Clinical trials of patient education for chronic conditions: A comparative meta-analysis of intervention types","volume":"14","author":"Dolan","year":"1985","journal-title":"Preventive Medicine"},{"issue":"20","key":"10.1002\/14651858.CD004371.pub3-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD004371.pub3-BIB122|cit122","article-title":"Detection, adherence and control of hypertension for the prevention of stroke: a systematic review","volume":"2","author":"Ebrahim","year":"1998","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB123|cit123","article-title":"Interventions for enhancing medication adherence","author":"Haynes","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB124|cit124","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005025.pub2","article-title":"Reminder packaging for improving adherence to self-administered long-term medications","author":"Heneghan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004371.pub3-BIB125|cit125","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]","author":"Higgins","year":"2008"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004371.pub3-BIB127|cit127","series-title":"Paper presented at the Fourth International Cochrane Colloquium, 20-24 Oct 1996; Adelaide, Australia","article-title":"Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE","author":"Lefebvre","year":"1996"},{"key":"10.1002\/14651858.CD004371.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.327.7419.841","article-title":"Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes","volume":"327","author":"Lewis","year":"2003","journal-title":"BMJ"},{"issue":"19","key":"10.1002\/14651858.CD004371.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004371.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/8.suppl_I.39","article-title":"Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial","volume":"8 Suppl 1","author":"Maenpaa","year":"1987","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB131|cit131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2125.1991.tb03923.x","article-title":"Medication compliance and serum lipid changes in the Helsinki Heart Study","volume":"32","author":"Maenpaa","year":"1991","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD004371.pub3-BIB132|cit132","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reporting of meta-analyses of randomised controlled trials: the QUORUM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004371.pub3-BIB133|cit133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004371.pub3-BIB134|cit134","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/bmj.314.7082.691","article-title":"Compliance becomes concordance","volume":"314","author":"Mullen","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004371.pub3-BIB135|cit135","volume-title":"Statins for the prevention of cardiovascular events. [Available at http:\/\/www.nice.org.uk\/nicemedia\/pdf\/TA094guidance.pdf accessed 11\/01\/09]","year":"2006"},{"issue":"9","key":"10.1002\/14651858.CD004371.pub3-BIB136|cit136","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB137|cit137","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"7272","key":"10.1002\/14651858.CD004371.pub3-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/bmj.321.7272.1322","article-title":"Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey","volume":"321","author":"Primatesta","year":"2000","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD004371.pub3-BIB139|cit139","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00005650-199808000-00004","article-title":"Effectiveness of interventions to improve patient compliance: a meta- analysis","volume":"36","author":"Roter","year":"1998","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD004371.pub3-BIB140|cit140","volume-title":"From compliance to concordance: towards shared goals in medicine taking","year":"1997"},{"key":"10.1002\/14651858.CD004371.pub3-BIB141|cit141","volume-title":"From compliance to concordance: towards shared goals in medicine taking","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB142|cit142","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001442.pub2","article-title":"Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV\/AIDS","author":"Rueda","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004371.pub3-BIB143|cit143","volume-title":"Compliance with therapeutic regimens","author":"Sackett","year":"1976"},{"issue":"14","key":"10.1002\/14651858.CD004371.pub3-BIB144|cit144","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004371.pub3-BIB145|cit145","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004371.pub2","article-title":"Interventions for improving adherence to lipid lowering medication","author":"Schedlbauer","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB146|cit146","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004804","article-title":"Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings","author":"Schroeder","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"20","key":"10.1002\/14651858.CD004371.pub3-BIB147|cit147","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004371.pub3-BIB148|cit148","volume-title":"Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. [Available at http:\/\/www.sign.ac.uk\/pdf\/sign97.pdf; accessed 11\/01\/09]","year":"2007"},{"key":"10.1002\/14651858.CD004371.pub3-BIB149|cit149","unstructured":"College Station,TX: Stata Corporation Stata Corp. Stata Statistical Software: Release 8.0 2002"},{"issue":"1","key":"10.1002\/14651858.CD004371.pub3-BIB150|cit150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/j.1875-9114.1997.tb03685.x","article-title":"Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug","volume":"17","author":"Straka","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB151|cit151","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1592\/phco.21.6.576.34541","article-title":"Poor adherence with hypolipidemic drugs: a lost opportunity","volume":"21","author":"Tsuyuki","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB152|cit152","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2165\/00003088-199427030-00004","article-title":"Role of patient compliance in clinical pharmacokinetics: A review of recent research","volume":"27","author":"Urquhart","year":"1994","journal-title":"Clinical Pharmacokinetics"},{"issue":"5","key":"10.1002\/14651858.CD004371.pub3-BIB153|cit153","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: three decades of research. A comprehensive review","volume":"26","author":"Vermeire","year":"2001","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004371.pub3-BIB154|cit154","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003638.pub2","article-title":"Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus","author":"Vermeire","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004371.pub3-BIB155|cit155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/heart.88.3.229","article-title":"Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study","volume":"88","author":"Wei","year":"2002","journal-title":"Heart (British Cardiac Society)"},{"key":"10.1002\/14651858.CD004371.pub3-BIB156|cit156","volume-title":"The World Health Report 2002 - Reducing risks, promoting healthy life. Available at http:\/\/www.who.int\/whr\/2002\/en\/ [accessed 4\/12\/09]","year":"2002"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004371.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004371.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T03:49:34Z","timestamp":1711338574000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004371.pub3"}},"subtitle":[],"editor":[{"given":"Angela","family":"Schedlbauer","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":156,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004371.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004371.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2010,3,17]]}}}